Who owns iShares Biotechnology ETF (IBB)? Elite investor 13F holders
5 tracked elite investors reported holding iShares Biotechnology ETF as of 2026-06-30, including D.E. Shaw, Gotham Asset Management, Renaissance Technologies LLC, Tudor Investment, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
5 tracked investors currently reported holding · Latest report period: 2026-06-30
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | ISHARES TR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 13117594.00 USD | 68971.000000 | Shares | reduce | Original filing |
| Gotham Asset Management | ISHARES TR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4473079.00 USD | 23519.000000 | Shares | add | Original filing |
| Renaissance Technologies LLC | ISHARES TR | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 4203199.00 USD | 22100.000000 | Shares | add | Original filing |
| Tudor Investment | ISHARES TR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3182259.00 USD | 16732.000000 | Shares | buy | Original filing |
| Ancora Advisors / Ancora Holdings | ISHARES TR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 325690.00 USD | 1712.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.